The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 13, 2019

Filed:

Mar. 28, 2016
Applicant:

University of Rochester, Rochester, NY (US);

Inventors:

Richard G. Moore, Victor, NY (US);

Rakesh K. Singh, Barrington, RI (US);

Naohiro Yano, Lincoln, RI (US);

Assignee:

University of Rochester, Rochester, NY (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C07H 21/02 (2006.01); A61K 31/7105 (2006.01); A61K 45/06 (2006.01); A61K 31/5025 (2006.01); A61K 31/58 (2006.01); A61K 31/713 (2006.01); A61P 35/00 (2006.01); A61K 33/24 (2019.01); A61K 45/00 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7105 (2013.01); A61K 31/5025 (2013.01); A61K 31/58 (2013.01); A61K 31/713 (2013.01); A61K 33/24 (2013.01); A61K 45/05 (2013.01); A61K 45/06 (2013.01); A61K 48/0016 (2013.01); A61K 48/0066 (2013.01); A61P 35/00 (2018.01); G01N 33/57484 (2013.01); A61K 2300/00 (2013.01); C12N 2310/11 (2013.01); C12N 2310/122 (2013.01);
Abstract

Provided herein, inter alia, are methods and compositions directed to suppressing tumor cell growth in a subject as well as methods for sensitizing a proliferating cell for treatment with a cytotoxic agent via inhibiting expression of HE4 and one or more immune checkpoint inhibitors (ICIs). Also provided herein are methods for determining whether a subject who has been diagnosed with cancer would benefit from immunotherapy as well as methods for determining whether a subject with cancer is responding to immunotherapy via assessment of levels of HE4 gene and/or protein expression.


Find Patent Forward Citations

Loading…